Research programme: zolpidem transmucosal - BioDelivery Sciences International

Drug Profile

Research programme: zolpidem transmucosal - BioDelivery Sciences International

Alternative Names: BEMA™ zolpidem; Transmucosal zolpidem

Latest Information Update: 28 Aug 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BioDelivery Sciences International
  • Class Acetamides; Hypnosedatives; Pyridines; Sleep disorder therapies; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Insomnia

Most Recent Events

  • 12 Apr 2007 Zolpidem transmucosal is available for partnering worldwide (
  • 15 Mar 2006 Preclinical trials in Insomnia in USA (Transmucosal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top